Senior lecturer in translational paediatric haemopoiesis

01 May 2011

Professor Tessa Holyoake, University of Glasgow

We have provided funding for a new senior research post, to lead a new childhood leukaemia team at the Paul O’Gorman Leukaemia Research Centre in Glasgow. The basic remit of the new team will be to carry out research into the causes, mechanisms and treatment of childhood leukaemia, with a special focus on acute myeloid leukaemia.

Amount of grant: £323,603  |  Date of award: May 2011

Some of the research team talk about the importance of this funding.
Professor Tessa Holyoake, Professor of Experimental Haematology. Dr Karen Keeshan, Senior Lecturer/Group Leader.
Dr Chris Halsey, Scottish Senior Clinical Research Fellow & Honorary NHS Consultant Paediatric Haematologist.

Background

We helped to fund the cost of building and equipping the new Paul O’Gorman Leukaemia Research Centre in Glasgow, which opened in 2008.

The new Centre forms part of Glasgow’s Institute of Cancer Sciences (ICS), providing a highly interactive research environment where basic scientists and clinical academics benefit from close interactions with the Beatson Institute of Cancer Research, the Royal Hospital for Sick Children and the Beatson West of Scotland Cancer Centre.

Read more: Paul O’Gorman Leukaemia Research Centre, Glasgow

New research into acute myeloid leukaemia

We have worked with Professor Tessa Holyoake, Director of the Paul O’Gorman Leukaemia Research Centre, to provide funding for a new senior research post, to lead a new childhood leukaemia team.

The basic remit of the new team will be to carry out research into the causes, mechanisms and treatment of childhood leukaemia, with the firm intention to translate research findings into improved patient care.

Within the childhood leukaemias, the main focus will be on acute myeloid leukaemia (AML). Whilst AML accounts for only around 15 per cent of cases of childhood leukaemia, the outlook is significantly worse than for children with more common form of leukaemia, acute lymphoblastic leukaemia (ALL). There is an urgent need for improved treatments for childhood AML.

The new research team will benefit from interactions with basic scientists and clinicians working on multiple aspects of childhood leukaemia, within the Centre and across Glasgow. This will enable best progress to be made in their research into childhood leukaemia, specifically AML.

Find out more


Professor Tessa Holyoake, Director of the Paul O’Gorman Leukaemia Research Centre at the University of Glasgow, talks about the work of the centre.

Lewis's story

At two-and-a-half Lewis was diagnosed with AML - Lewis's mum Claire tell their story.
PostCounter

Where your money goes

Hover over a segment for details

NCRI AMRC